Ovarian Cancer Clinical Trials in Pittsburgh

Showing 221-224 of 224 trials

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814

The purpose of this study is to improve upon and validate the prognostic and/or predictive accuracy of a drug response marker by the development of improved alternative algorithms based on the actual clinical outcome of retrospective cases.

Ovarian CancerPeritoneal CancerFallopian Tube Cancer

Precision Therapeutics512 participantsStarted Aug 2009

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 3< 1 mile

Clinical Trial for Ovarian Cancer (OvaRex®)

NCT00050375

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Ovarian Cancer

Unither Pharmaceuticals354 participantsStarted Dec 2002

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +59 more locations

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer Trials in Other Cities

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Other Conditions in Pittsburgh